Targeting Anaplastic Lymphoma Kinase (ALK) in...

Targeted Oncology 2017 / 10

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib

van Erp, Anke E. M., Hillebrandt-Roeffen, Melissa H. S., van Houdt, Laurens, Fleuren, Emmy D. G., van der Graaf, Winette T. A., Versleijen-Jonkers, Yvonne M. H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Targeted Oncology
DOI:
10.1007/s11523-017-0528-z
Date:
October, 2017
File:
PDF, 1.32 MB
english, 2017
Conversion to is in progress
Conversion to is failed